ICH Considerations: general principles to address virus and vector shedding

Current version

PDF iconICH Considerations

Reference numberEMEA/CHMP/ICH/449035/2009
KeywordsGene therapy medicinal products, gene therapy, shedding, analytical assays, non-clinical, clinical
DescriptionThis document provides recommendations for designing non-clinical and clinical virus/vector shedding studies. In particular, it emphasizes the analytical assays used for detection and considerations for the sampling profiles and schedules in both non-clinical and clinical studies. The interpretation of non-clinical data and its use in designing clinical studies is also within the scope of this paper, as well as the interpretation of clinical data in assessing the need for virus/vector transmission studies.

Related content

How useful was this page?

Add your rating